Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (TSE:MRMD)
:MRMD
Total Valuation
MariMed has a market cap or net worth of C$41.40M. The enterprise value is C$162.38M.
Market CapC$41.40M
Enterprise ValueC$162.38M
Share Statistics
MariMed has 382.17M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding382.17M
Owened by Insiders10.17%
Owened by Instutions0.19%
Financial Efficiency
MariMed’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is 5.32%.
Return on Equity (ROE)-15.42%
Return on Assets (ROA)-5.88%
Return on Invested Capital (ROIC)5.32%
Return on Capital Employed (ROCE)1.84%
Revenue Per EmployeeC$220,928.671
Profits Per Employee-C$17,012.587
Employee Count715
Asset Turnover0.76
Inventory Turnover2.84
Valuation Ratios
The current PE Ratio of MariMed is -3.58. MariMed’s PEG ratio is 0.13.
PE Ratio-3.58
PS Ratio0.28
PB Ratio0.55
Price to Fair Value0.55
Price to FCF-7.40
Price to Operating Cash Flow6.42
PEG Ratio0.13
Income Statement
In the last 12 months, MariMed had revenue of C$157.96M and earned -C$12.16M in profits. Earnings per share was -C$0.02.
RevenueC$157.96M
Gross ProfitC$49.45M
Operating IncomeC$3.35M
Pretax Income-C$3.97M
Net Income-C$12.16M
EBITDA14.27M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -C$413.00K and capital expenditures -C$711.00K, giving a free cash flow of -C$1.12M billion.
Operating Cash Flow-C$413.00K
Free Cash Flow-C$1.12M
Free Cash Flow per Share>-C$0.01
Dividends & Yields
MariMed pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-13.52%
Earnings Yield-27.93%
Stock Price Statistics
Beta0.94
52-Week Price Change-68.12%
50-Day Moving Average0.16
200-Day Moving Average0.20
Relative Strength Index (RSI)38.16
Average Volume (3m)69.78K
Important Dates
MariMed upcoming earnings date is May 7, 2025, TBA.
Last Earnings DateMar 5, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
MariMed as a current ratio of 1.10, with Debt / Equity ratio of 1.12
Current Ratio1.10
Quick Ratio0.41
Debt to Market Cap2.03
Net Debt to EBITDA27.88
Interest Coverage Ratio0.42
Taxes
In the past 12 months, MariMed has paid C$8.16M in taxes.
Income TaxC$8.16M
Effective Tax Rate-205.62%
Enterprise Valuation
MariMed EV to EBITDA ratio is 42.83, with an EV/FCF ratio of -21.19.
EV to Sales0.79
EV to EBITDA42.83
EV to Free Cash Flow-21.19
EV to Operating Cash Flow18.38
Balance Sheet
MariMed has C$7.28M in cash and marketable securities with C$88.47M in debt, giving a net cash position of C$81.19M billion.
Cash & Marketable SecuritiesC$7.28M
Total DebtC$88.47M
Net CashC$81.19M
Net Cash Per ShareC$0.21
Tangible Book Value Per ShareC$0.12
Margins
Gross margin is 39.80%, with operating margin of 1.84%, and net profit margin of -7.70%.
Gross Margin39.80%
Operating Margin1.84%
Pretax Margin-2.51%
Net Profit Margin-7.70%
EBITDA Margin1.84%
EBIT Margin1.88%
Analyst Forecast
The average price target for MariMed is C$0.35, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$0.35
Price Target Upside216.60%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast